Age limit does not replace serologic testing for determination of immune status for measles

Infection Control and Hospital Epidemiology

Volumn 28, Issue 9, 2007, Pages 1117-1120

  Uçkay, Ilker ^a   Hugonnet, Stéphane ^a   Kaiser, Laurent ^a   Sax, Hugo ^a   Pittet, Didier ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HUMAN; IMMUNE STATUS; IMMUNOCOMPETENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MASS SCREENING; MEASLES; SEROLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODY FORMATION; CROSS INFECTION; DISEASE OUTBREAKS; HUMANS; IMMUNOCOMPETENCE; MEASLES; MEASLES VACCINE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; SWITZERLAND;

EID: 34548339665     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/519928     Document Type: Article

References (22)

1. Steingart KR, Thomas AR, Dykewicz CA, Redd SC. Transmission of measles virus in healthcare settings during a community-wide outbreak. Infect Control Hosp Epidemiol 1999; 20:115-119.
2. Swiss Federal Office of Public Health. Eidgenössische Komission für Impffragen (EKIF). Schweizerischer Impfplan 2006. Richtinien und Empfehlungen. Bern: Swiss Federal Office of Public Health; 2006.
3. Immunization of healthcare workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1997; 46(RR-18):1-42.
4. Ljungman P, Aschan J, Barkholt L, et al. Measles immunity after allogeneic stem cell transplantation: influence of donor type, graft type, intensity of conditioning, and graft-versus host disease. Bone Marrow Transplant 2004; 34:589-593.
5. Kremer JR, Schneider F, Muller CP. Waning antibodies in measles and rubella vaccines - a longitudinal study. Vaccine 2006; 24:2594-2601.
6. Dhiman N, Ovsyannikova IG, Ryan JE, et al. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination. Clin Exp Immunol 2005; 142:498-504.
7. Masserey E, Bouvier P, Brenner E, et al. Vaccinal coverage and its determinants in preschool children in Vaud canton in 1996. Rev Med Suisse Romande 1998; 118:309-315.
8. Anderson RM, May RM. Immunisation and herd immunity. Lancet 1990; 335:641-645.
9. Çelikbaş, A, Ergonul O, Aksaray S, et al. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Am J Infect Control 2006; 34:583-587.
10. Hatakeyama S, Moriya K, Itoyama S, et al. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan. Infect Control Hosp Epidemiol 2004; 25:591-594.
11. Ammari LK, Bell LM, Hodinka RL. Secondary measles vaccine failure in healthcare workers exposed to infected patients. Infect Control Hosp Epidemiol 1993; 14:81-86.
12. Ferson MJ. Control of infections in child care. Med J Aust 1994; 161: 615-618.
13. Fedeli U, Zanetti C, Saia B. Susceptibility of healthcare workers to measles, mumps, rubella and varicella. J Hosp Infect 2002; 51:133-135.
14. Ziegler E, Roth C, Wreghitt T. Prevalence of measles susceptibility among health care workers in a UK hospital: does the UK need to introduce a measles policy for its health care workers? Occup Med (Lond) 2003; 53:398-402.
15. Willy ME, Koziol DE, Fleisher T, et al. Measles immunity in a population of healthcare workers. Infect Control Hosp Epidemiol 1994; 15:12-17.
16. Kim M, LaPointe J, Liu FJ. Epidemiology of measles immunity in a population of healthcare workers. Infect Control Hosp Epidemiol 1992; 13:399-402.
17. Asari S, Deguchi M, Tahara K, et al. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Am J Infect Control 2003; 31:157-162.
18. Seo SK, Malak SF, Lim S, Eagan J, Sepkowitz KA. Prevalence of measles antibody among young adult healthcare workers in a cancer hospital: 1980s versus 1998-1999. Infect Control Hosp Epidemiol 2002; 23:276-278.
19. Wright LJ, Carlquist JF. Measles immunity in employees of a multihospital healthcare provider. Infect Control Hosp Epidemiol 1994; 15:8-11.
20. Almuneef MA, Memish ZA, Balkhy HH, Otaibi B, Helmi M. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Infect Control Hosp Epidemiol 2006; 27:1178-1183.
21. Krause PJ, Gross PA, Barrett TL, et al. Quality standard for assurance of measles immunity among health care workers. Infectious Diseases Society of America. Clin Infect Dis 1994; 18:431-436.
22. Mühlemann K, Aebi C, Zysset F, Francioli P. Vaccination du personnel hospitalier contre la rougeole, les oreillons et la rubéole. Swiss-NOSO Bulletin 2001; 8:13-15. Available at: http://www.swiss-noso. ch. Accessed June 27, 2007.